Oct 21 () - AstraZeneca said on Wednesday the US Food and Drug Administration granted accelerated approval for its treatment for adults with immunoglobulin A nephropathy, a rare kidney disease that ...
Emirates News Agency on MSN
Department of Health – Abu Dhabi, Cleveland Clinic Abu Dhabi and AstraZeneca collaborate to advance clinical research
ABU DHABI, 21st October, 2026 (WAM) -- The Department of Health – Abu Dhabi (DoH), Cleveland Clinic Abu Dhabi and AstraZeneca launch a new collaboration positioning Abu Dhabi as a priority location in ...
Artificial Intelligence (AI) is revolutionizing the full lifecycle of innovative drug research and development (R&D), ...
Several Oncology Catalysts, One Earnings Question AstraZeneca PLC (NYSE:AZN) enters the3-27 European Society for Medical ...
Oracle Health AstraZeneca team explores AI to improve clinical trial recruitment and early patient identification across multiple disease areas.
On Tuesday, AstraZeneca ( AZN) and Amgen ( AMGN) said Tezspire met both co-primary and key secondary endpoints in the Phase 3 CROSSING trial in eosinophilic esophagitis, with improvements at week 24 ...
AstraZeneca ( AZN) said Tuesday that full results from the Phase 3 CROSSING trial showed Tezspire improved disease remission and swallowing symptoms in adolescents and adults with eosinophilic ...
AstraZeneca PLC (AZN) has announced a collaboration with Oracle Health and Life Sciences that pairs AstraZeneca’s scientific, clinical-development and regulatory expertise with Oracle’s ...
Jefferies, the investment bank, estimates a 59% probability that AstraZeneca PLC (LSE:AZN, NYSE:AZN)’s zibotentan succeeds in ...
AstraZeneca and Oracle will use AI and real-world health data to find trial patients sooner, starting with a hypertension ...
Oracle today announced an agreement with AstraZeneca to explore how AI and real-world data can help clinicians identify eligible patients for clinical trials, accelerate evidence generation, and bring ...
Oct 20 () - AstraZeneca said on Tuesday that it is working with Oracle to use AI and real-world data to identify eligible patients for clinical trials and monitor safety signals, among other ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results